Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Ciento cincuenta años del descubrimiento del bacilo de Hansen. Una mirada al pasado y una reflexión bioética

Sarmiento L. M. M. Revista Medecina. 2023; 45 (3) : 576-588.
Download PDF
Publication

Estratégias de autocuidado em hanseníase adotadas pelos profissionais da equipe multiprofissional de saúde

Sousa TEP, Aragão JMN, Brito NDN. Faculdade Paulo Picanço. Revista da Faculdade Paulo Picanço. 2023; 3 (4) : 1-22.
Download PDF
Publication

Hanseníase e agenda internacional sobre reabilitação e acessibilidade para pessoas com deficiência

Peruzzo P. P, Gonçalves N. I. G, Silva L. V. C. da. Revista Eletronica do Curso de Direito. 2023;
Download PDF
Publication

Cytokines profile in pure neural leprosy.

Pitta I, Angst D, Pinheiro R, et al. Frontiers in immunology. 2023;
Download PDF
Publication

Stigma, depression and quality of life among people affected by neglected tropical diseases in Nepal.

Thapa D, Dahal H, Chaulagain D, et al. International health. 2023; 15 (Supplement_3) : iii79-iii86.
Download PDF
Publication

Pure neuritic leprosy and Buerger’s disease: Not a cause -- maybe an association?

Narang T, Dogra S, Kumar B. Lepra. Leprosy Review. 2023; 94 (4) : 375-377.
Download PDF
Publication

Why we need to continue to target field workers and healthcare providers at the primary level to prevent visual loss in leprosy

Anand S. Lepra. Leprosy Review. 2023; 94 (4) : 372-374.
Download PDF
Publication

Building the resilience of leprosy-affected people: lessons from Bangladesh

Karim MM, Barua R, George S, et al. Lepra. Leprosy Review. 2023; 94 (4) : 369-371.
Download PDF
Publication

Dapsone induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, sparing leprosy patches as an ‘anatopic’ response: A case report

Hegde P, Reddy S, Pai K, et al. Lepra. Leprosy Review. 2023; 94 (4) : 354-357.
Download PDF
Publication

Effect of hope, spirituality and social support on quality of life among people affected by leprosy in Indonesia: A cross-sectional study

Nugraheni R, Murti B, Irwanto ME, et al. Lepra. Leprosy Review. 2023; 94 (4) : 332-340.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 113
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD